Transaction value optimisation specialists
A specialist operating unit
For transaction-focused MedTech, Digital Health, and Life Sciences businesses preparing for capital raising, scaling, sale, or exit.
Straterra works with post-seed startups and mid-market businesses approaching a value event. We identify the drivers suppressing enterprise value, implement the highest-impact improvements, and build the financial, operational, and market evidence needed for investor and acquirer confidence.
Built for businesses where valuation is necessary, not theoretical.
Straterra works with leaders who desire measurable valuation improvement before their next transaction, funding event, market entry, or strategic decision. Our work is focused, confidential, and tied to the drivers that influence enterprise value.
Post-seed
startups
Pressure on runway, proof, and the next funding milestone. We sharpen the commercials, financials and evidence that impact valuation.
Mid-market businesses approaching transaction
Preparing for growth capital, partial sale, strategic acquisition, or exit. We help close readiness gaps that can suppress enterprise value.
International companies onshoring R&D in Australia
Accessing Australia’s R&D capability and incentive environment. We help establish, manage, and optimise the operating structure.
Five drivers determine enterprise value.
Straterra’s work is anchored in a practical valuation framework. We assess where value is constrained, prioritise the highest-impact changes, and work with you as your operating partner to implement improvements that can be measured, reported, and defended.
01
Revenue
Quality
Visible, repeatable, resilient revenue.
02
Investor-Critical Financials
Cashflow, margin quality, and reporting maturity.
03
Operational Scaleability
Systems and processes that scale without proportional cost.
04
People
Factors
Capability that does not depend on fragile key-person risk.
05
Market
Position
Defensible differentiation, channel strength, and pricing power.
We deploy five ways to move enterprise value.
Our capabilities are designed to assess, optimise, and implement the changes that matter before a transaction, capital raise, market expansion, or R&D operating decision.
Valuation Readiness Assessment
Identify the drivers constraining enterprise value and prioritise the improvements that matter before capital, sale, exit, or strategic review.
BEST FOR
Optimising pre-transaction activities.
Cash Runway
Extension
Improve cash visibility, cost discipline, R&D incentive pathways, and runway resilience before the next value event.
BEST FOR
Closing the runway to value event gap.
Transaction Preparation
Prepare for capital, sale, or exit through two pathways: Series A Preparation and Sale and Exit Readiness.
BEST FOR
Preparing a defined transaction event.
Value Creation
Retainer
Embed senior operating support to implement priority value-uplift actions and track progress against investor-grade measures.
BEST FOR
Executing pre-transaction activities.
Australian R&D Operations
Establish Australian R&D operations to access onshore capability, incentive access, and compliance discipline.
BEST FOR
International businesses seeking optimised R&D tax efficiency.
Three sectors. Specific drivers. Measurable outcomes.
Straterra’s mission is to improve human health outcomes by focusing where enterprise value is shaped by evidence, execution, capital efficiency, and transaction readiness for businesses in the MedTech, Digital Health, and Life Sciences innovator space.
MedTech
Clinical, regulatory, IP, and capital milestones can determine how MedTech value is assessed.
Straterra helps prioritise the governance, evidence, and operating work required for transaction readiness.
Digital Health
Digital Health value depends on revenue quality, reimbursement logic, deployment scalability, and data defensibility.
Straterra helps turn market traction into a clearer investor or acquirer narrative.
Life Sciences
Life Sciences businesses need defensible evidence, repeatable demand, channel quality, and resilient margins.
Straterra helps sharpen the commercial and operational drivers that support durable value.
Straterra’s work is measured by outcomes that matter: runway extended, valuation drivers strengthened, transactions prepared, R&D cashflow improved, and enterprise value defended.
Proof belongs in the numbers.
USD $443M+
Combined exit value delivered.
3 major exits
Experience across completed transaction outcomes with globally recognised results.
AUD $200M+
Cashflow and operating resilience delivered via Australian R&D Tax Incentive optimisation.
Initiate a confidential mandate discussion.
If your business is approaching a capital raise, sale, exit, R&D operating decision, or valuation-critical growth phase, speak with Straterra. We will review the mandate, assess fit, and identify where focused implementation support can move enterprise value.
All enquiries are treated as confidential mandate discussions.